Document is current
Any future updates will be listed below
-
Authors
Peng, Daizhuang
Xu, Sumei
Zou, Ting
Wang, Yahui
Ouyang, Wenjuan
Zhang, Yalan
Dong, Chengmei
Li, Dai
Guo, Jie
Shen, Qiuying
Hu, Xiaolei
Zhou, Wenzhi
Li, Xiaomin
Qin, Qun
-
Funding
Funding for this research was provided by:
The South China Center for Innovative Pharmaceuticals
- License Information
-
More Information
Article History
Received: 25 April 2023
Accepted: 23 October 2023
First Online: 23 November 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice Guideline. Study protocols and all amendments were approved by the Medical Ethics Committee of Xiangya Hospital Central South University (approval numbers: 201812122/201904103/201812122–2, 202004089, 201908150). All subjects provided written informed consent before enrollment.
: Not applicable.
: Yahui Wang is an employee of the South China Center for Innovative Pharmaceuticals, which sponsored this study. The other authors declare no conflicts of interest.
